# a Single-arm, Single-center, Open Clinical Study

> **NCT06431100** · — · RECRUITING · sponsor: **Beijing Geekgene Technology Co., LTD** · enrollment: 10 (estimated)

## Conditions studied

- Gastric Cancer
- Esophageal Cancer
- Cervical Cancer
- Non-Small Cell Lung Cancer NSCLC
- Triple Negative Breast Cancer TNBC

## Interventions

- **BIOLOGICAL:** TCR T-cells

## Key facts

- **NCT ID:** NCT06431100
- **Lead sponsor:** Beijing Geekgene Technology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-19
- **Primary completion:** 2026-07-19
- **Final completion:** 2026-11-19
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06431100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06431100, "a Single-arm, Single-center, Open Clinical Study". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT06431100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*